NEW YORK--(BUSINESS WIRE)-- OWKIN, a predictive analytics company that utilizes transfer learning to accelerate drug discovery and development, today announced that Anna Bondarenko, Chief Operating Officer, will present an overview of the Company’s business and will be available to participate in one-on-one meetings with investors at the Digital Medicine & Medtech Showcase ™ 2018 Conference to be held January 8-10, 2018, in San Francisco, CA.

The details of OWKIN’s presentation are as follows:

• Event: Digital Medicine & Medtech Showcase 2018 ™Conference
• Date: Tuesday, January 9, 2018
• Time: 1:15 pm PT / 4:15pm ET
• Location: B-Cyril Magnin III (4^th Floor), Parc 55 San Francisco

For more information about the conference, visit: https://ebdgroup.knect365.com/digimed-showcase/agenda/1

Connect with OWKIN

•  LinkedIn
• Twitter

About OWKIN

OWKIN is a predictive analytics company that utilizes transfer learning to accelerate drug discovery and development. OWKIN’s proprietary platform, OWKIN Plus uses machine learning-based modeling to analyze molecular, imaging libraries and patient datasets to uncover complex biomarker patterns that cause disease. OWKIN partners with leading pharmaceutical companies including Amgen and Actelion and the Company has programs in development with Institut Curie, Centre Leon Berard and Saint Louis Hospital. For more information, visit www.owkin.com and follow @OWKINscience on Twitter.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171219005747/en/